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A. Lejay, N. Chakfe *
Department of Vascular Surgery and Kidney Transplantation, University Hospital of Strasbourg, Strasbourg, FranceIn their paper, Menting et al.1 evaluated the potential role of
remote ischemic preconditioning (RIPC) to reduce contrast
induced nephropathy (CIN) through a randomized clinical trial.
The trial failed to demonstrate any improvement of serum
creatinine level in the RIPC arm, but found that RIPC might have
beneﬁcial effects in patients at high risk of CIN. This is an
extremely interesting topic that might help in clinical practice
since more and more endovascular procedures are performed in
an ageing population presenting more and more comorbidities,
including impaired renal function.
Menting et al.1 considered the change in serum creatinine
from baseline to 48e72 hours after contrast administration as
the primary outcome. Although creatinine is widely used, it is a
suboptimal marker of renal injury because it does not rapidly
reﬂect the altered glomerular ﬁltration rate or degree of tubular
injury.2 In CIN, the creatinine level increases from 24 to 48 hours
after contrast exposure and peaks within 2e5 days. Further-
more, renal function must decrease by more than half before an
increase in serum creatinine is detected. Urinary excretion of
liver type fatty acid binding protein (L-FABP) as been showed to
be an early biomarker that reﬂects tubulo-interstitial damage,
including ischemic and toxic injury, and peaks within 24 hours
after contrast administration, justifying the use of urinary L-FABP
for the early detection of contrast induced nephropathy.3 Igar-
ashi et al.3 showed that RIPC attenuated the prevalence of L-
FABP based contrast induced nephropathy after angiographic
procedures in patients with low to moderate risk, without any
difference in the serum creatinine level between the RIPC and
control groups. In their trial, Menting et al.1 failed to demon-
strate any improvement of serum creatinine level in the RIPC
arm, but the use of both serum creatinine level and urinary L-
FABP might have been interesting.
The second point is that contrast induced vasoconstriction is
not the only factor involved in CIN. The mechanism of CIN is
actually multifactorial, and the pathogenesis involves combined
hypoxic and toxic renal tubular damage with renal endothelial
dysfunction and decreased intrarenal microcirculation. TheDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2015.04.002
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http://dx.doi.org/10.1016/j.ejvs.2015.05.001infusion of contrast medium with the attendant increase in os-
motic load and viscosity elicits hypoxia of the renal medulla and
leads to renal free radical production via post-ischemic oxidative
stress. Free radicals are a double edged sword. They can be
harmful by inducing oxidative stress leading to protein carboxyl-
ation, lipid peroxidation, and DNA damage, but can be beneﬁcial
via the cell signaling involved in the antioxidant defense network
whenproduced in smaller amounts.4 In the control group, patients
received sham preconditioning by inﬂation of the blood pressure
cuff to 10mmHg below the actual diastolic pressure for 5 minutes
followed by 5minutes of reperfusion (four cycles). Even if the level
of ischemia induced by this sham treatment can be considered to
be negligible, a certain inﬂuence cannot be ruled out.
The last point in this study is the proportion of diabetic
patients in the trial (28% in the sham group, and 22% in the
RIPC group). Oxidative stress plays a central role in contrast
induced nephropathy, and the mechanism of ischemic condi-
tioning includes the activation of intracellular pro-survival
pathways. There are numbers of studies showing that these
pro-survival pathways are impaired in the diabetic state.5
However, these studies have been conducted in the cardiac
ﬁeld, and it is well known that the diabetic state is a limiting
factor in ischemic conditioning.
In conclusion, this paper investigates a very interesting topic,
highlighting the need for new strategies including ischemic
conditioning to prevent contrast induced nephropathy, espe-
cially in high risk patients.REFERENCES
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